πŸ‡ΊπŸ‡Έ FDA
Patent

US 11851433

Compounds, compositions and methods

granted A61PA61P25/16A61P25/28

Quick answer

US patent 11851433 (Compounds, compositions and methods) held by DENALI THERAPEUTICS INC. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P25/16, A61P25/28